Glaniknase Injection
Prescription Required
Product introduction
Glaniknase Injection is a medicine used to break down harmful blood clots that have formed in the blood vessels. It is used to treat patients who have suffered a recent heart attack. It is also used in treating conditions such as pulmonary embolism and stroke.
Glaniknase Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. The doctor may closely monitor your condition until you become stable.
Use of this medicine may cause injection site bleeding, nausea, allergic reaction, and a decrease in blood pressure. It may increase your risk of bleeding also. Your doctor will explain the benefits and risks associated with this medicine before it is administered. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
This medicine is used with caution for some people. Thus, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
Glaniknase Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. The doctor may closely monitor your condition until you become stable.
Use of this medicine may cause injection site bleeding, nausea, allergic reaction, and a decrease in blood pressure. It may increase your risk of bleeding also. Your doctor will explain the benefits and risks associated with this medicine before it is administered. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
This medicine is used with caution for some people. Thus, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
Uses of Glaniknase Injection
Side effects of Glaniknase Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glaniknase
- Allergic reaction
- Nausea
- Injection site bleeding
- Decrease in blood pressure
How to use Glaniknase Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Glaniknase Injection works
Glaniknase Injection works by dissolving the harmful blood clots in the blood vessels. This restores the blood flow to the affected tissue, thereby preventing tissue death and improving outcomes.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Glaniknase Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Glaniknase Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Glaniknase Injection during breastfeeding is not available. Please consult your doctor.
Driving
NOT RELEVANT
Not relevant, as Glaniknase Injection is intended for use in hospitalised patients.
Kidney
SAFE IF PRESCRIBED
Glaniknase Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Glaniknase Injection may not be needed in these patients. Please consult your doctor.
Use of Glaniknase Injection is not recommended in patients with severe kidney disease.
Use of Glaniknase Injection is not recommended in patients with severe kidney disease.
Liver
CAUTION
Glaniknase Injection should be used with caution in patients with severe liver disease. Dose adjustment of Glaniknase Injection may be needed. Please consult your doctor.
What if you forget to take Glaniknase Injection?
If you miss a dose of Glaniknase Injection, please consult your doctor.\n
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Glaniknase Injection
₹2071/Injection
Ecokinase Injection
Delvin Formulations Pvt Ltd
₹2351.43/injection
10% costlier
Quick tips
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g. football, wrestling).
- Do not discontinue use without consulting your doctor as this may increase your chances of having another heart attack or stroke.
- Glaniknase Injection helps break down blood clots in blood vessels, thereby treating conditions such as heart attack, pulmonary embolism, and stroke.
- It should be given as soon as possible (within 12 hours) after the onset of a heart attack.
- It is usually given by your nurse or doctor as an infusion (drip) into a vein.
- It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g. football, wrestling).
- Do not discontinue use without consulting your doctor as this may increase your chances of having another heart attack or stroke.
Fact Box
Chemical Class
Amino acids, Peptides analogues
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
First-Generation Thrombolytics
Interaction with drugs
Taking Glaniknase with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Concurrent use may increase the risk of bleeding. Streptokinase may increase the effect of Apixaban.
Do not consume Apixaban with Streptokinase. If concurrent use is essential, wat
Urokinase may reduce the efficacy of Streptokinase.
Do not consume Streptokinase with Urokinase. If Streptokinase is essential, ensure a gap of At least 5 days between taking Stre
Concurrent use may increase the risk of bleeding.
Inform your doctor if you notice any signs of bleeding (bruising, bleeding gums, blood in stool/vomit/urine).
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and bruising and consult your doctor immediately.
Concurrent use may increase the risk of bleeding.
If concurrent use is essential, watch out for bleeding and consult your doctor immediately.
Patient concerns
FAQs
Can the use of Glaniknase Injection increase the risk of bleeding?
Yes, Glaniknase Injection increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
What medicines should I avoid while taking Glaniknase Injection?
Glaniknase Injection can interact with several medicines. Do not take any medicine without talking to your doctor.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 384-85.
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 866.
- Drugs.com. Streptokinase Pregnancy and Breastfeeding Warnings. [Accessed 20 Mar. 2019] (online) Available from:
Marketer details
Name: Gland Pharma Limited
Address: Gland Pharma Limited, 6-3-865/1/2, Greenland Apartments, Ameerpet, Hyderabad - 500016, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present